Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH
- PMID:2830315
- PMCID: PMC442524
- DOI: 10.1172/JCI113382
Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH
Abstract
The diurnal response of ACTH release to intravenously administered arginine vasopressin was tested in normal volunteers given consecutively moderate doses of vasopressin every 15 min (0.1, 0.3, 1.0, and 3.0 IU) at 2200 h and again at 0700 h (PM/AM). This protocol was repeated 4 wk later with the times reversed (AM/PM). A dose-related increase in ACTH secretion was observed in all subjects. When the AM response of the AM/PM protocol was compared with the PM response of the PM/AM protocol, the release of ACTH was greater in the morning (P less than 0.05) as evaluated by the following criteria: peak value of ACTH (129.9 +/- 30.4 pg/ml in the AM vs. 57.1 +/- 20.2 in the PM); area under the curve (689 in the AM vs. 259 in the PM); and, sensitivity of the ACTH dose-response curve (first significant increase in ACTH with 1 IU of vasopressin in the AM but not significant even after 3 IU in the PM). In addition, when the AM vasopressin testing followed a previous evening stimulation (PM/AM protocol), there was a blunted ACTH response compared with the AM/PM protocol. Corticotropin-releasing factor (CRF) is probably the major ACTH secretagogue, but since vasopressin acts synergistically with CRF to produce an augmented release of ACTH, we suggest that the ACTH response to administered vasopressin depends upon the ambient endogenous level of CRF. We interpret our data and published data that CRF produces a lesser release of ACTH in the AM as follows: in the morning endogenous CRF is high and administered CRF produces little further release of ACTH, but administered vasopressin acting synergistically with high endogenous CRF causes a greater release of ACTH; conversely, in the evening endogenous CRF is low and administered CRF causes a greater release of ACTH, but vasopressin (a weak secretagogue by itself) gives a low ACTH response. We conclude that vasopressin stimulation of ACTH secretion can be used as an in vivo bioassay of endogenous CRF, and that there is a diurnal rhythm of CRF in hypophyseal portal blood.
Similar articles
- Stress-induced adrenocorticotropin secretion: diurnal responses and decreases during stress in the evening are not dependent on corticosterone.Bradbury MJ, Cascio CS, Scribner KA, Dallman MF.Bradbury MJ, et al.Endocrinology. 1991 Feb;128(2):680-8. doi: 10.1210/endo-128-2-680.Endocrinology. 1991.PMID:1846585
- Corticotropin-releasing factor alone, but not arginine vasopressin alone, stimulates the release of adrenocorticotropin in the conscious intact sheep.McFarlane A, Coghlan J, Tresham J, Wintour EM.McFarlane A, et al.Endocrinology. 1995 May;136(5):1821-7. doi: 10.1210/endo.136.5.7720626.Endocrinology. 1995.PMID:7720626
- Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo.Rivier C, Vale W.Rivier C, et al.Endocrinology. 1983 Sep;113(3):939-42. doi: 10.1210/endo-113-3-939.Endocrinology. 1983.PMID:6307672
- [Role of the neurohypophysis in psychological stress].Scantamburlo G, Ansseau M, Legros JJ.Scantamburlo G, et al.Encephale. 2001 May-Jun;27(3):245-59.Encephale. 2001.PMID:11488255Review.French.
- The physiology of corticotropin-releasing factor (CRF).Raux-Demay MC, Girard F.Raux-Demay MC, et al.Reprod Nutr Dev (1980). 1985;25(5):931-43. doi: 10.1051/rnd:19850709.Reprod Nutr Dev (1980). 1985.PMID:3001878Review.
Cited by
- Autonomic and endocrine control of cardiovascular function.Gordan R, Gwathmey JK, Xie LH.Gordan R, et al.World J Cardiol. 2015 Apr 26;7(4):204-14. doi: 10.4330/wjc.v7.i4.204.World J Cardiol. 2015.PMID:25914789Free PMC article.Review.
- Diagnostic accuracy and comparison of BIPSS in response to lysine vasopressin and hCRH.Jarial KDS, Bhansali A, Gupta V, Singh P, Mukherjee KK, Sharma A, Vashishtha RK, Sukumar SP, Sachdeva N, Walia R.Jarial KDS, et al.Endocr Connect. 2018 Mar;7(3):425-432. doi: 10.1530/EC-18-0046. Epub 2018 Feb 12.Endocr Connect. 2018.PMID:29440131Free PMC article.
- Early postoperative HPA-axis testing after pituitary tumor surgery: reliability and safety of basal cortisol and CRH test.de Vries F, Lobatto DJ, Bakker LEH, van Furth WR, Biermasz NR, Pereira AM.de Vries F, et al.Endocrine. 2020 Jan;67(1):161-171. doi: 10.1007/s12020-019-02094-6. Epub 2019 Sep 25.Endocrine. 2020.PMID:31556005Free PMC article.
- Metabolic effects of vasopressin in pathophysiology of diabetic kidney disease.Lebedeva S, Margaryan A, Smolyarchuk E, Nedorubov A, Materenchuk M, Tonevitsky A, Mutig K.Lebedeva S, et al.Front Endocrinol (Lausanne). 2023 Sep 18;14:1176199. doi: 10.3389/fendo.2023.1176199. eCollection 2023.Front Endocrinol (Lausanne). 2023.PMID:37790608Free PMC article.Review.
- Effect of tolvaptan on hyponatremia in a dog with syndrome of inappropriate secretion of antidiuretic hormone.Yamamoto H, Kimura K, Horikirizono H, Tamura Y, Kambayashi S, Baba K, Okuda M, Mizuno T, Igase M.Yamamoto H, et al.J Vet Med Sci. 2023 Oct 17;85(10):1047-1051. doi: 10.1292/jvms.23-0243. Epub 2023 Aug 16.J Vet Med Sci. 2023.PMID:37587049Free PMC article.
References
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources